Publication:
Demographic, clinical and management characteristics of newly diagnosed COPD patients in Turkey: A real-life study

dc.contributor.authorSuerdem, Mecit
dc.contributor.authorGünen, Hakan
dc.contributor.authorAkyıldız, Levent
dc.contributor.authorÇilli, Aykut
dc.contributor.authorÖzlü, Tevfik
dc.contributor.authorAbadoğlu, Öznur
dc.contributor.authorBayram, Hasan
dc.contributor.authorCimrin, Arif Hikmet
dc.contributor.authorGemicioğlu, Bilun
dc.contributor.authorMısırlıgil, Zeynep
dc.contributor.buuauthorUzaslan, Esra
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentGöğüs Hastalıkları Bölümü
dc.contributor.researcheridAAI-1004-2021
dc.contributor.scopusid8761653500
dc.date.accessioned2024-01-29T12:38:26Z
dc.date.available2024-01-29T12:38:26Z
dc.date.issued2020
dc.description.abstractPurpose: In order to determine the clinical and sociodemographic characteristics of newly diagnosed treatment-naïve asthma and COPD patients in Turkey, a multicenter study in 2012 was initiated . We aimed to investigate the characteristics and therapies of COPD patients in the original study in more detail. Patients and Methods: This nation-wide, multicentric, non-interventional, prospective, real-life observational cohort study was conducted in 122 centers. The newly diagnosed patients were not receiving any treatment before the recruitment. Their general characteristics, the combined GOLD 2011 COPD categories and exacerbation histories were noted. The patients were followed up with 3 voluntary visits for 1 year. Their adherence to the inhaled treatment according to GOLD 2011 was evaluated during follow-up visits. Results: The study included 776 COPD patients. Their mean age was 59.4±9.1 years, and 11.9% of the patients were female. 35.1% of the patients were in the GOLD 2011 C and D category. 12.6% are frequent exacerbators, and 52.8% had at least one comorbid condition. 71.8% overtreatment rate was detected. Their attendance rates for three follow-up visits became 55.9%, 32.9% and 18.7%, respectively. The adherence rate to the treatment was measured as 81.9%. Conclusion: Although these patients were diagnosed for the first time, the GOLD C and D categories and frequent exacerbator phenotype were found at a high rate. They were usually prescribed an overtreatment regimen. We think that newly diagnosed COPD patients should be evaluated carefully, and best effort should be made to treat these patients in accordance with the recommendations of the major COPD guidelines.
dc.description.sponsorshipAbdi Ibrahim Ilac San. ve Tic. AS, Turkey
dc.description.sponsorshipAbdi Ibrahim
dc.description.sponsorshipSanofi
dc.description.sponsorshipAstraZeneca
dc.description.sponsorshipNovartis
dc.description.sponsorshipDeva
dc.identifier.citationUzunaslan, E. vd. (2020). ''Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study''. International Journal of Chronic Obstuctive Pulmonary Disease, 15, 261-267.
dc.identifier.doihttps://doi.org/10.2147/COPD.S211838
dc.identifier.endpage267
dc.identifier.issn1178-2005
dc.identifier.pubmed32103925
dc.identifier.scopus2-s2.0-85079468793
dc.identifier.startpage261
dc.identifier.urihttps://www.dovepress.com/demographic-clinical-and-management-characteristics-of-newly-diagnosed-peer-reviewed-fulltext-article-COPD
dc.identifier.urihttps://hdl.handle.net/11452/39369
dc.identifier.volume15
dc.identifier.wos000515242300001
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherDove Medical Press Ltd.
dc.relation.collaborationYurt içi
dc.relation.collaborationSanayi
dc.relation.journalInternational Journal of Chronic Obstuctive Pulmonary Disease
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCOPD
dc.subjectNewly diagnosed
dc.subjectTreatment naive
dc.subjectExacerbations
dc.subjectObstructive pulmonary-disease
dc.subjectHealt-status
dc.subjectAsthma
dc.subjectComorbidities
dc.subjectPrevalence
dc.subjectSpirometry
dc.subjectCountries
dc.subjectOutcomes
dc.subject.emtreeBeta adrenergic receptor stimulating agent
dc.subject.emtreeCorticosteroid
dc.subject.emtreeLong acting drug
dc.subject.emtreeMuscarinic receptor blocking agent
dc.subject.emtreeRespiratory tract agent
dc.subject.emtreeAdult
dc.subject.emtreeArticle
dc.subject.emtreeChronic obstructive lung disease
dc.subject.emtreeCohort analysis
dc.subject.emtreeComorbidity
dc.subject.emtreeControlled study
dc.subject.emtreeDisease exacerbation
dc.subject.emtreeDisease severity
dc.subject.emtreeFemale
dc.subject.emtreeFollow up
dc.subject.emtreeHuman
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeMedication compliance
dc.subject.emtreeMiddle aged
dc.subject.emtreeObservational study
dc.subject.emtreePatient attendance
dc.subject.emtreePatient compliance
dc.subject.emtreePrescription
dc.subject.emtreeProspective study
dc.subject.emtreeTurkey (republic)
dc.subject.emtreeAged
dc.subject.emtreeChronic obstructive lung disease
dc.subject.emtreeClinical practice
dc.subject.emtreeClinical trial
dc.subject.emtreeDrug utilization
dc.subject.emtreeMedication overuse
dc.subject.emtreeMulticenter study
dc.subject.emtreePathophysiology
dc.subject.emtreePractice guideline
dc.subject.emtreeProtocol compliance
dc.subject.emtreeTreatment outcome
dc.subject.emtreeTurkey (bird)
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshComorbidity
dc.subject.meshDisease progression
dc.subject.meshDrug utilization
dc.subject.meshFemale
dc.subject.meshGuideline adherence
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMedication adherence
dc.subject.meshMiddle aged
dc.subject.meshPractice guidelines as topic
dc.subject.meshPractice patterns
dc.subject.meshPhysicians'
dc.subject.meshPrescription drug overuse
dc.subject.meshProspective studies
dc.subject.meshPulmonary disease
dc.subject.meshChronic obstructive
dc.subject.meshRespiratory system agents
dc.subject.meshTreatment outcome
dc.subject.meshTurkey
dc.subject.scopusChronic Obstructive Lung Disease; Spirometry; Primary Care
dc.subject.wosRespiratory system
dc.titleDemographic, clinical and management characteristics of newly diagnosed COPD patients in Turkey: A real-life study
dc.typeArticle
dc.wos.quartileQ2
dc.wos.quartileQ2
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Göğüs Hastalıkları Bölümü
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: